Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 14221-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#14221-1-AP, RRID:AB_2221547
- Product name
- ACTN2 antibody
- Antibody type
- Polyclonal
- Description
- ACTN2 antibody (Cat. #14221-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IF, IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Incomplete Assembly of the Dystrophin-Associated Protein Complex in 2D and 3D-Cultured Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Targeting of CAT and VCAM1 as Novel Therapeutic Targets for DMD Cardiomyopathy.
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis.
Biomimetic electrical stimulation induces rat bone marrow mesenchymal stem cells to differentiate into cardiomyocyte-like cells via TGF-beta 1 in vitro.
Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy.
MiR-466h-5p induces expression of myocardin with complementary promoter sequences.
Early Deсline in Rat Soleus Passive Tension with Hindlimb Unloading: Inactivation of Cross-bridges or Activation of Calpains?
Gilbert G, Kadur Nagaraju C, Duelen R, Amoni M, Bobin P, Eschenhagen T, Roderick HL, Sampaolesi M, Sipido KR
Frontiers in cell and developmental biology 2021;9:737840
Frontiers in cell and developmental biology 2021;9:737840
Targeting of CAT and VCAM1 as Novel Therapeutic Targets for DMD Cardiomyopathy.
Li B, Xiong W, Liang WM, Chiou JS, Lin YJ, Chang ACY
Frontiers in cell and developmental biology 2021;9:659177
Frontiers in cell and developmental biology 2021;9:659177
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
Xu Y, Xu F, Lv Y, Wang S, Li J, Zhou C, Jiang J, Xie B, He F
Scientific reports 2021 Mar 18;11(1):6374
Scientific reports 2021 Mar 18;11(1):6374
Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
Schuldt M, Johnston JR, He H, Huurman R, Pei J, Harakalova M, Poggesi C, Michels M, Kuster DWD, Pinto JR, van der Velden J
Journal of molecular and cellular cardiology 2021 Jan;150:77-90
Journal of molecular and cellular cardiology 2021 Jan;150:77-90
LncRNA-Mhrt regulates cardiac hypertrophy by modulating the miR-145a-5p/KLF4/myocardin axis.
Xu Y, Luo Y, Liang C, Zhang T
Journal of molecular and cellular cardiology 2020 Feb;139:47-61
Journal of molecular and cellular cardiology 2020 Feb;139:47-61
Biomimetic electrical stimulation induces rat bone marrow mesenchymal stem cells to differentiate into cardiomyocyte-like cells via TGF-beta 1 in vitro.
He X, Li L, Tang M, Zeng Y, Li H, Yu X
Progress in biophysics and molecular biology 2019 Nov;148:47-53
Progress in biophysics and molecular biology 2019 Nov;148:47-53
Possible mechanism of GATA4 inhibiting myocardin activity during cardiac hypertrophy.
Xu Y, Liang C, Luo Y, Xing W, Zhang T
Journal of cellular biochemistry 2019 Jun;120(6):9047-9055
Journal of cellular biochemistry 2019 Jun;120(6):9047-9055
MiR-466h-5p induces expression of myocardin with complementary promoter sequences.
Luo Y, Liang C, Xu Y, Zhang T
Biochemical and biophysical research communications 2019 Jun 18;514(1):187-193
Biochemical and biophysical research communications 2019 Jun 18;514(1):187-193
Early Deсline in Rat Soleus Passive Tension with Hindlimb Unloading: Inactivation of Cross-bridges or Activation of Calpains?
Petrova IO, Tyganov SA, Mirzoev TM, Tsaturyan AK, Kozlovskaya IB, Shenkman BS
Doklady. Biochemistry and biophysics 2018 Jul;481(1):205-207
Doklady. Biochemistry and biophysics 2018 Jul;481(1):205-207
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The ACTN2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human ACTN2. This antibody recognizes human, mouse, rat antigen. The ACTN2 antibody has been validated for the following applications: ELISA, WB analysis.